Pfizer UK is separated into a number of business divisons, offering a diverse range of opportunities.
You can find out more about the culture, development opportunities and benefits Pfizer offers by using the links on the left side.
Pfizer Global Pharmaceuticals
Pfizer Global Pharmaceuticals (PGP) brings the prescription medicines of our leading research pipeline to patients and physicians. Join this vibrant division and you’ll become an integral part of an organisation of dedicated professionals – and the UK’s largest supplier of medicines to the NHS. Your work will improve the
lives of the two million UK patients who take a Pfizer medicine every month.
Our therapeutics areas include:
Allergy & Respiratory
Antibacterials
Antifungals
Antivirals
Cardiovascular
Central Nervous System
Dermatology (Anaderm)
Diabetes/Obesity
Gastrointestinal
Immunology
Inflammation
Oncology
Ophthalmology
Osteoporosis/Frailty
Pain
Sexual Health
Urology
Pfizer Global Research and Development
The Pfizer Global Research and Development (PGRD) division finds new treatments, advancing the frontiers of science and medicine to help make lives all over the world happier, healthier and longer. Our UK base at Sandwich employs 2,700 scientists – to which you might be the next invaluable addition.
Pfizer Global Manufacturing
Working for Pfizer Global Manufacturing (PGM) means working for the largest division of Pfizer Inc. In fact, one in every four of your colleagues worldwide works in this essential division responsible for the manufacture and supply of Pfizer's portfolio of health care products for people and animals in the UK.
Pfizer Global Animal Health
Pfizer Animal Health is the largest supplier of animal medicines in the world and the UK. We have direct marketing operations in more than 30 countries and distribution and export operations in 20 more. Our diverse range of animal specific medicines extends to treatments for Cattle, Swine, Sheep, Poultry and Companion animals. Each of our animal medicines is highly successful in their markets and demonstrates the diverse nature of Pfizer’s portfolio.